FRCS, Research Associate and Senior Registrar.
Clinical outcome and quality of life following enterocystoplasty for idiopathic detrusor instability and neurogenic bladder dysfunction
Article first published online: 21 NOV 2008
British Journal of Urology
Volume 76, Issue 5, pages 551–557, November 1995
How to Cite
HASAN, S.T., MARSHALL, C., ROBSON, W.A. and NEAL, D.E. (1995), Clinical outcome and quality of life following enterocystoplasty for idiopathic detrusor instability and neurogenic bladder dysfunction. British Journal of Urology, 76: 551–557. doi: 10.1111/j.1464-410X.1995.tb07777.x
- Issue published online: 21 NOV 2008
- Article first published online: 21 NOV 2008
- Accepted for publication 27 June 1995
- Detrusor instability;
- bladder reconstruction;
- quality of life;
Objective To study the long-term outcome of patients undergoing enterocystoplasty.
Patients and methods The study comprised 48 patients (17 men and 31 women; mean age 46 years) who underwent enterocystoplasty for idiopathic detrusor instability (DI, 35 patients) or neurogenic bladder dysfunction (13 patients). Symptoms were scored from 0 to 14 and the overall outcome and generic quality of life were assessed using a Visick grading system (groups A to E) and the Nottingham Health Profile (NHP). These assessments were carried out before, 3 months after operation and at the final follow-up (38 ± 18 months, range 13–78). Urodynamic studies were performed before and after operation.
Results No patient died after operation and there was minimal early morbidity. Late complications (>30 days) included incisional hernia (3), anastomotic perforation (1), calculus formation (1) and urethral stricture (1). Clean intermittent self-catheterization (CISC) was performed by 36 (75%) patients. Early symptomatic outcome was good in 40 (83%) patients, moderate in seven (15%) and unsatisfactory in one (2%) patient. The mean symptom scores before and 3 months after surgery were 10 (range 2–14) and 3 (range 2–14), respectively (P < 0.001). There was a significant increase in total bladder capacity (307±140 to 588±217 mL; P < 0.001) and bladder compliance (37±50 to 169±162 mL/cm H2O; P < 0.001). DI persisted in 15 (31%) patients. NHP scores revealed significant improvements in all domains. Final assessment showed a less satisfactory situation, with recurrent urinary tract infection (UTI) in 17 (3 7%) patients, a need for long-term antibiotic therapy in seven (15%) and a change in bowel habit in 15 (33%) (13 DI, two with neurogenic bladder dysfunction). CISC was performed by 39 (85%) patients. The long-term outcome was good or moderate in 12 patients (92%) with neurogenic bladder dysfunction and good or moderate in only 19 patients (58%) with DI.
Conclusion Clam enterocystoplasty remains an effective management option in some patients with DI, but most patients with neurogenic bladder dysfunction do well. The procedure is, however, associated with long-term complications such as disturbance of bowel habit and recurrent UTIs, which impair the outcome in the long-term in patients with DI despite general improvements in irritative bladder symptoms.